You just read:

Bird Rock Bio's Gerilimzumab, an Anti-IL-6 Antibody, Demonstrates Potential for Affordable Global Access to a Novel Biologic to Treat Rheumatoid Arthritis

News provided by

Bird Rock Bio, Inc.

Mar 16, 2016, 03:00 ET